BIOMAT Database Logo BIOMAT Database Logo

Oral bile acids in cystic fibrosis-associated liver disease. 1994

C Colombo, and A Crosignani, and M G Apostolo, and M T Marzano, and N Bettinardi, and A Giunta
Department of Paediatrics, University of Milan, Italy.

UI MeSH Term Description Entries
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D014580 Ursodeoxycholic Acid An epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic. Deoxyursocholic Acid,3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid,Cholit-Ursan,Cholofalk,Delursan,Destolit,Sodium Ursodeoxycholate,Urdox,Ursacholic Acid,Urso,Urso Heumann,Ursobilane,Ursochol,Ursodiol,Ursofalk,Ursogal,Ursolite,Ursolvan,3 alpha,7 beta Dihydroxy 5 beta cholan 24 oic Acid,Acid, Deoxyursocholic,Acid, Ursacholic,Acid, Ursodeoxycholic,Ursodeoxycholate, Sodium
D016032 Randomized Controlled Trials as Topic Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table. Clinical Trials, Randomized,Controlled Clinical Trials, Randomized,Trials, Randomized Clinical

Related Publications

C Colombo, and A Crosignani, and M G Apostolo, and M T Marzano, and N Bettinardi, and A Giunta
Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
May 1996, European journal of gastroenterology & hepatology,
C Colombo, and A Crosignani, and M G Apostolo, and M T Marzano, and N Bettinardi, and A Giunta
Cystic fibrosis-associated liver disease.
October 2010, Best practice & research. Clinical gastroenterology,
C Colombo, and A Crosignani, and M G Apostolo, and M T Marzano, and N Bettinardi, and A Giunta
[Cystic fibrosis associated with liver disease].
May 2012, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
C Colombo, and A Crosignani, and M G Apostolo, and M T Marzano, and N Bettinardi, and A Giunta
Cystic fibrosis associated liver disease in children.
November 2021, World journal of hepatology,
C Colombo, and A Crosignani, and M G Apostolo, and M T Marzano, and N Bettinardi, and A Giunta
Cystic fibrosis-associated liver disease in children.
October 2020, Minerva pediatrica,
C Colombo, and A Crosignani, and M G Apostolo, and M T Marzano, and N Bettinardi, and A Giunta
Liver disease and common-bile-duct stenosis in cystic fibrosis.
February 1988, The New England journal of medicine,
C Colombo, and A Crosignani, and M G Apostolo, and M T Marzano, and N Bettinardi, and A Giunta
Serum bile acids in cystic fibrosis patients - glycodeoxycholic acid as a potential marker of liver disease.
January 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
C Colombo, and A Crosignani, and M G Apostolo, and M T Marzano, and N Bettinardi, and A Giunta
Markers of cystic fibrosis-associated liver disease.
April 2001, Journal of pediatric gastroenterology and nutrition,
C Colombo, and A Crosignani, and M G Apostolo, and M T Marzano, and N Bettinardi, and A Giunta
Ursodeoxycholic acid in cystic fibrosis-associated liver disease.
January 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,
C Colombo, and A Crosignani, and M G Apostolo, and M T Marzano, and N Bettinardi, and A Giunta
Liver disease and bile duct abnormalities in adults with cystic fibrosis.
December 1989, Lancet (London, England),
Copied contents to your clipboard!